Introduction
Heat Shock Protein 90 (Hsp90) is an essential molecular chaperone in eukaryotic cells (Jackson et al., 2004; Neckers, 2007; Pearl and Prodromou, 2006) . It creates and maintains the functional conformation of a subset of proteins that are referred to as "client proteins" -typically key components of multiple regulatory and signalling networks that mediate cancer cell proliferation, survival, and metastasis (Wandinger et al., 2008) . Therefore Hsp90 has become an attractive target for new cancer therapeutics (Whitesell and Lindquist, 2005; Workman and de Billy, 2007) , even though a full understanding of the chaperoning requirements of discrete clients remains poorly understood.
Hsp90 chaperone activity depends on ATP binding and hydrolysis (Obermann et al., 1998; Panaretou et al., 1998) , which is coupled to a conformational cycle involving the opening and closing of a dimeric "molecular clamp" via transient association of Hsp90's N-terminal domains . ATP binds to the N-domain of Hsp90 (Prodromou et al., 1997) , which also binds the Hsp90 inhibitor geldanamycin (GA) (Grenert et al., 1997; Stebbins et al., 1997) . Hsp90 ATPase activity is regulated by co-chaperones. For example, Hop Sti1 (Chang et al., 1997) , p50 Cdc37 (Lee et al., 2004; Vaughan et al., 2008) , and p23 Sba1 (McLaughlin et al., 2006; Picard, 2006) inhibit the Hsp90 ATPase cycle, while Aha1 (Panaretou et al., 2002) , and Cpr6 (Johnson et al., 2007) stimulate it.
Hsp90 in solution does not have a single 'relaxed' conformation but exists as a continuum of conformations; ATP binding subtly shifts the equilibrium to favor transient formation/ stabilization of a 'tense' state in which N-domains are dimerized (Graf et al., 2009) . Recent studies have shown that the steady-state population density of these conformations is uniquely species dependent (Southworth and Agard, 2008 ). An earlier study reported that cancer cell Hsp90, in contrast to the bulk of the chaperone in non-transformed cells, preferentially adopts a tense (closed) conformation (Kamal et al., 2003) . Together, these observations suggest that the dynamics of the Hsp90 chaperone cycle may be significantly influenced by epigenetic factors, including unique post-translational modifications (Scroggins and Neckers, 2007) . Numerous literature reports identify Hsp90 as a phosphoprotein, and they show that Hsp90 phosphorylation impacts its function (Duval et al., 2007; Kurokawa et al., 2008; Lees-Miller and Anderson, 1989; Mimnaugh et al., 1995; Zhao et al., 2001) .
Saccharomyces cerevisiae Wee1 (Swe1) is an Hsp90 client and also the only "true" tyrosine kinase in budding yeast (http://db.yeastgenome.org), (Aligue et al., 1994; Goes and Martin, 2001 ). Swe1 Wee1 phosphorylates and inhibits the kinase activity of the main cell cycle cyclindependent kinase Cdc28p (human Cdc2), thereby regulating the G2/M transition (Booher et al., 1993; Harvey and Kellogg, 2003; Lew, 2003; McGowan and Russell, 1993) .
Tyrosine phosphorylation of Hsp90 in yeast has not been reported previously. In the present study, we show that Swe1 Wee1 directly phosphorylates a conserved tyrosine residue in the Ndomain of Hsp90. Mutation of this residue to non-phosphorylatable phenylalanine did not affect Hsp90 ATPase activity, productive in vivo chaperoning of glucocorticoid receptor, or yeast viability, but did negatively impact chaperoning of certain Hsp90 clients including v-Src and heat shock factor (HSF). Identical effects on the chaperoning of these clients were observed in yeast expressing wild type (wt) Hsp90 but lacking Swe1. Further, purified Wee1 phosphorylated both yeast and human Hsp90 proteins on the same residue in vitro. Finally, GA bound preferentially to Hsp90 from swe1Δ yeast, and pharmacologic inhibition/silencing of Wee1 sensitized cancer cells to Hsp90 inhibitor-induced apoptosis.
Results

Swe1 phosphorylates Hsp90 in yeast
To evaluate Hsp90 tyrosine phosphorylation in Saccharomyces cerevisiae, we used the wt PP30 yeast strain in which both copies of endogenous Hsp90 (Hsp82 and Hsc82) are deleted and replaced with a single copy of Hsp82 that is His6 tagged at the N-terminus (yHsp90-His 6 ) . Blotting with a phospho-tyrosine-specific antibody demonstrated constitutive tyrosine phosphorylation of yHsp90His 6 after pulldown with Ni-NTA agarose ( Figure 1A ). Yeast Hsp90-His 6 tyrosine phosphorylation was significantly reduced in cells treated with GA for 1 hr ( Figure 1A ). Direct phosphorylation of Hsp90 by Swe1 has not been described previously. Swe1 expression is cell cycle-regulated, appearing most prominently in S-phase (Asano et al., 2005; Liu and Wang, 2006) . We noticed that GA treatment for 1 hr, which significantly reduced yeast Hsp90 (yHsp90) tyrosine phosphorylation ( Figure 1A ), also decreased the S phase population ( Figure  S1 ).
To query further the possible involvement of Swe1 in tyrosine phosphorylation of Hsp90, we utilized swe1Δ cells. Although viable, these cells lack G2/M checkpoint controls and undergo premature entry into mitosis (Harvey and Kellogg, 2003; Lew, 2003) . Hsp90-His 6 tyrosine phosphorylation was undetectable in swe1Δ cells ( Figure 1B ).
In order to obtain further evidence for the Swe1 dependence of yHsp90 tyrosine phosphorylation, we expressed an N-terminally glutathione-S-transferase (GST) tagged Swe1 under the galactose inducible promoter GAL1 in swe1Δ cells. Swe1-GST expression was undetectable in cells grown in raffinose media (due to repression of the GAL1 promoter) ( Figure  1C ). Tyrosine phosphorylation of yHsp90-His 6 was also not detected in these cells. Swe1-GST was induced by addition of galactose for 30 min, and this coincided with appearance of tyrosine phosphorylated yHsp90-His 6 ( Figure 1C ). Additionally, Swe1-GST was co-precipitated with yHsp90-His 6 (detected with anti-GST antibody). These data indicate that Swe1 mediates tyrosine phosphorylation of yHsp90.
Tyrosine phosphorylation of yHsp90 is cell cycle-associated and leads to Hsp90 ubiquitination and degradation by cytoplasmic proteasomes As Swe1 synthesis and degradation is cell cycle regulated, we wished to determine whether cell cycle phase affected yHsp90 tyrosine phosphorylation. We examined the distribution of tyrosine-phosphorylated yHsp90 in cells arrested in G1-phase with α-factor, in S-phase with hydroxyurea (HU), or in M-phase with nocodazole (NOC). As shown in Figure 2A , yHsp90 tyrosine phosphorylation was more pronounced in S-phase than in an asynchronized log-phase population, and was absent or markedly reduced in G1 and M-phase-arrested cells (Figure 2A ). These observations were confirmed by examining the temporal status of yHsp90 tyrosine phosphorylation in yeast cells released from G1 arrest by removal of α-factor. yHsp90 phosphorylation increased to a maximum after 40 min ( Figure S2 ), which corresponds to S phase (Asano et al., 2005; Liu and Wang, 2006) . These data indicate that yHsp90 tyrosine phosphorylation is cell cycle-associated and coincident with both Swe1 expression and Y19 phosphorylation of the known Swe1 substrate Cdc28 (Figure 2A ).
The steady-state level of protein phosphorylation usually depends on the interplay between kinases and phosphatases. However, we were unable to identify a tyrosine phosphatase responsible for dephosphorylating yHsp90 when we screened the S. cerevisiae tyrosine phosphatase mutant collection from EUROSCARF (http://web.unifrankfurt.de/fb15/mikro/euroscarf/). To rule out the possibility of redundancy among yeast phosphatases, we treated yeast cells with the protein phosphotyrosine phosphatase inhibitor potassium bisperoxo(1,10-phenanthroline)oxovanadate (bpVphen) (Faure et al., 1995) . Mid-log phase yeast cells were treated with 0.1 mM bpVphen for different times. While Y19 Cdc28 phosphorylation increased noticeably within 15 min, confirming the effectiveness of phosphatase inhibition, we observed no change in tyrosine phosphorylation of yHsp90 even after exposure of cells to bpVphen for 180 min ( Figure 2B ).
Given our inability to detect phosphatase-dependent dephosphorylation of yHsp90, even though no tyrosine phosphorylated species was detected in either M-phase or G1-phasearrested cells, we next explored the possibility that tyrosine phosphorylation of yHsp90 may serve as a signal for its ubiquitination and subsequent proteasome-mediated degradation. Supporting this possibility, treatment of yeast cells with the proteasome inhibitor MG132, under conditions that caused neither a heat shock response nor cell cycle arrest (data not shown), resulted in an accumulation of tyrosine phosphorylated and ubiquitinated yHsp90 (top 2 panels, Figure 2C ). To confirm that the signals obtained with the antibodies detecting phospho-tyrosine and ubiquitin were due to yHsp90 and not to adventitious proteins accompanying the Ni-NTA agarose pulldown of yHsp90-His 6 , we salt-stripped the pulldowns and repeated the blotting with identical results ( Figure 2C ). To demonstrate the efficacy of the salt-stripping procedure, we confirmed that it disrupted co-precipitation of Swe1-HA ( Figure  2C ). Lastly, yHsp90 ubiquitination was not observed in swe1Δ cells ( Figure 2C ), or in cells expressing only yHsp90-Y24F (see explanatory text below, Figure S2 ), supporting the hypothesis that tyrosine phosphorylation of yHsp90 precedes and is a prerequisite for its ubiquitination in yeast.
In order to determine the subcellular location of yHsp90 ubiquitination, we synchronized yeast cells in S-phase with HU, or we treated an asynchronous population with MG132. Yeast Hsp90-His 6 was then precipitated from nuclear and cytoplasmic protein fractions and assessed for tyrosine phosphorylation and ubquitination status. Purity of nuclear and cytoplasmic protein fractions was assessed by blotting for the nuclear protein Nop1 and the cytoplasmic protein α-tubulin, respectively. Our data show that in untreated, asynchronized yeast cells most tyrosine phosphorylated yHsp90 is in the nucleus ( Figure 2D ). However, both S-phase arrest and proteasome inhibition caused an increase in tyrosine phosphorylated yHsp90 in both nuclear and cytoplasmic fractions, with the greatest increase appearing in the cytoplasm ( Figure  2D ). Importantly, only yHsp90 in the cytoplasmic fraction was ubiquitinated after either treatment ( Figure 2D ). These data are consistent with a model in which tyrosine phosphorylated yHsp90 is ubiquitinated and degraded in the cytoplasm. Our findings suggest that tyrosine phosphorylation of yHsp90 occurs primarily in the nucleus during S-phase, and that the tyrosine phosphorylated species exits the nucleus prior to its ubiquitination.
Hsp90 is phosphorylated by Swe1 Wee1 on a single conserved tyrosine residue in the Ndomain
In order to identify the tyrosine residue(s) that are phopshorylated by Swe1, we queried the crystal structures of yHsp90 individual domains as well as that of the full length dimer (Ali et al., 2006; Meyer et al., 2003) . We identified Y24, Y47, Y508 and Y606 as tyrosine residues likely to be surface-exposed on yHsp90. After mutating each residue independently to the nonphosphorylatable amino acid phenylalanine (F), we expressed yHsp90-His 6 harboring each mutation in yeast and we assessed its tyrosine phosphorylation status. Only Y24F mutation abrogated tyrosine phosphorylation of yHsp90 ( Figure 3A ).
Tyrosine 24 in yeast Hsp90 is highly conserved in eukaryotic Hsp90 proteins, including human Hsp90α (hHsp90α, where the equivalent residue is Y38). However, it is not possible to specifically observe the phosphorylation status of Y38 in hHsp90α using a pan antiphosphotyrosine antibody because hHsp90α is subject to tyrosine phosphorylation at several other residues (Duval et al., 2007; Scroggins and Neckers, 2007) . Therefore, we used yeast strains that expressed either wt hHsp90α (Millson et al., 2007) or hHsp90α-Y38F as the sole Hsp90 protein. After immunoprecipitating hHsp90α, we probed Western blots with an antiphosphotyrosine antibody. While wt hHsp90α was phosphorylated, hHsp90-Y38F was not, confirming Y38 as the sole phosphorylated tyrosine residue in hHsp90α expressed in yeast ( Figure 3B ).
Unlike budding yeast, the human genome contains 90 tyrosine kinase genes and five presumed tyrosine kinase pseudogenes. Therefore, in the absence of an antibody that uniquely recognizes tyrosine phosphorylated Y38, it is impossible to demonstrate Hsp90 tyrosine phosphorylation by Wee1 in human cells. Instead, we bacterially expressed and purified N-terminally His6-tagged yeast and human wt Hsp90, as well as yHsp90-Y24F and hHsp90α-Y38F ( Figure S3 ). These proteins (bound to Ni-NTA agarose) were used as substrates in an in vitro kinase assay that included purified, active Wee1-GST. Under these conditions, Wee1-GST efficiently phosphorylated yeast and human wt Hsp90 proteins but not yHsp90-Y24F or hHsp90α-Y38F ( Figure 3C, D) . These results provide strong evidence that Wee1 can directly phosphorylate Y24 of yHsp90 and Y38 of hHsp90α in the absence of other proteins or co-chaperones. Further, Y24/Y38 is the only tyrosine residue of these Hsp90 proteins that is phosphorylated by Swe1 Wee1 .
Mutation of Y24 affects Hsp90 ATPase activity and N-domain dimerization
In order to gain further insight into the impact of Y24/Y38 phosphorylation on Hsp90 function, we mutated Y24 in yHsp90 and Y38 in hHsp90α to the phosphomimic residue glutamic acid (E). Unfortunately, these phosphomimic Hsp90 mutants were unable to support yeast viability ( Figure 4A ). We obtained similar results with alternative phosphomimic aspartic acid (D) mutants ( Figure S4 ). The lethality of these mutants is likely due to a nearly complete lack of ATPase activity (Y24E < 3% of wt, Figure 4B ) and failure to undergo N-domain dimerization in the presence of AMPPNP (a non-hydrolyzable ATP analog) ( Figure 4C, D) . In contrast, the non-phosphorylatable mutants Y24F (yHsp90) and Y38F (hHsp90) are viable ( Figure 4A ), display normal ATPase activity, and undergo AMPPNP-mediated N-domain dimerization (Figure 4 B -D) . As Y24F and Y24E mutants bind AMPPNP with a K d similar to that of wt yHsp90 ( Figure 4B ), it is likely that loss of ATPase activity of yHsp90-Y24E is due to lack of ATP-dependent N-domain dimerization and subsequent conformational events.
Y24/Y38 mutation affects Hsp90 interaction with and chaperoning of distinct client proteins
Yeast Hsp90-Y24F supports viability and has normal ATPase activity but cannot be phosphorylated. Therefore, we utilized this protein to query the possible importance of Swe1-mediated Hsp90 phosphorylation for distinct aspects of chaperone function. Since Y24F mutation may engender structural alteration of Hsp90 unrelated to Y24 phosphorylation, we also used swe1Δ cells expressing wt yHsp90, in which we have shown that phosphorylation of Y24 is absent.
We first examined the interaction and stability of two endogenous yeast Hsp90 client proteins, the kinases Ste11 (a Raf-1 ortholog) (Louvion et al., 1998) and activated Mpk1/Slt2 (an Erk5 ortholog) (Millson et al., 2004) . Ste11ΔN, a constitutively active allele that causes pheromoneindependent activation of the mating pathway (under GAL1 promoter) was expressed in wt cells upon transfer from glucose to galactose media ( Figure 5A ). However we were unable to detect Ste11 in swe1Δ cells or in yeast expressing yHsp90-Y24F ( Figure 5A ). Mpk1/Slt2 MAP kinase activation strengthens its interaction with yHsp90 (Millson et al., 2004) . We detected interaction of wt yHsp90 with Mpk1/Slt2 in cells stressed with 10 mM caffeine (activator of the cell wall integrity pathway in yeast). However, interaction of Mpk1/Slt2 with yHsp90-Y24F and yHsp90 from swe1Δ cells was significantly reduced ( Figure 5B ). These data strongly suggest that phosphorylation of yHsp90-Y24 is important for chaperoning of at least two endogenous kinase clients in yeast.
The oncogenic tyrosine kinase v-Src is a well-known Hsp90 client protein (Nathan and Lindquist, 1995) . Active v-Src expression in yeast requires Hsp90 and causes lethality due to de-regulated phosphorylation of yeast proteins. This has become a widely used reporter assay in yeast for analysis of Hsp90 chaperone function. Expression of v-Src under a galactose inducible GAL1 promoter in either swe1Δ cells or in yeast expressing yHsp90-Y24F as the sole Hsp90 failed to cause lethality, unlike v-Src expression in wt cells ( Figure 5C ). Further analysis revealed that v-Src protein and v-Src-mediated phosphorylation of total yeast proteins were clearly detectable in wt cells, but not in either swe1Δ cells or in yeast expressing yHsp90-Y24F as the sole Hsp90 ( Figure 5D ). Importantly, v-Src activation displayed the same cell cycle pattern as yHsp90 tyrosine phosphorylation ( Figure S5 ). Thus, as with the endogenous kinases Ste11 and Mpk1/Slt2, Y24 phosphorylation status appears to be an important determinant for productive chaperoning of v-Src in yeast.
We next looked at the impact of yHsp90-Y24F or SWE1 deletion on the activity of two Hsp90-dependent transcription factors -heat shock factor (HSF) and glucocorticoid receptor (GR). It is generally held that Hsp90 binding serves to down-regulate HSF transcriptional activity (Zou et al., 1998) . Mutation of Hsp90, or Hsp90 inhibitor administration, leads to induction of HSF activity in yeast, even in the absence of heat shock. (Hjorth-Sorensen et al., 2001; Piper et al., 2003) . We measured HSF activity in swe1Δ yeast cells and in yeast expressing yHsp90-Y24F by transforming these cells with a plasmid-based lacZ HSF reporter, HSE-lacZ (see Supplemental Experimental Procedures). As shown in Figure 5E , both swe1Δ cells and yHsp90-Y24F mutants displayed elevated basal and heat-induced (39°C for 40 min) HSF activity compared to wt cells. These results indicate that Y24 phosphorylation contributes to the ability of yHsp90 to suppress HSF activity, consistent with the observation that, unlike the case in metazoans, HSF1 is constitutively present in the nucleus in yeast (Morimoto, 1998) .
The mammalian steroid receptor GR is another well-characterized Hsp90-dependent transcription factor that provides a sensitive readout for Hsp90 function in yeast cells (Pratt et al., 2004) . To assess the impact of Y24 phosphorylation on the chaperoning of GR, yHsp90-Y24F, swe1Δ, and wt cells were transformed with a plasmid constitutively expressing GR and carrying a glucocorticoid-regulated lacZ reporter gene. In this case, neither the swe1Δ cells nor the yHsp90-Y24F-expressing cells were significantly impaired for GR activity compared to wt cells ( Figure 5F ).
Since Swe1 Wee1 phosphorylated human hHsp90α both in vitro and in vivo ( Figure 3B, D) , we assessed the impact of Y38F mutation on interaction of hHsp90α with several kinase and steroid receptor client proteins in mammalian cells. First, we transiently expressed either FLAGtagged wt hHsp90α or FLAG-tagged hHsp90α-Y38F in v-Src-transformed NIH-3T3 fibroblasts. Following immunoprecipitation of v-Src, we detected robust interaction with FLAG-tagged wt hHsp90α, but its interaction with the Y38F mutant was markedly reduced ( Figure 5G ). We observed similar results with another Hsp90 kinase client, ErbB2. COS7 cells were co-transfected with either FLAG-tagged wt hHsp90α or Y38F mutant plasmids, and with plasmid expressing ErbB2. While we were able to co-immunoprecipitate ErbB2 with wt FLAG-hHsp90α, ErbB2 interaction with hHsp90α-Y38F was noticeably impaired ( Figure 5H ). Finally, we examined association of the endogenous client kinase Raf-1 with hHsp90α-Y38F in PC3 prostate cancer cells and we saw a similar reduced interaction compared to wt hHsp90α ( Figure 5I ). Importantly, these results were reproduced when we examined the impact of siRNA-mediated silencing of Wee1 on the endogenous Hsp90/Raf-1 interaction in PC3 cells ( Figure 5J ).
In contrast to these results, when we compared the interaction of wt hHsp90 and hHsp90-Y38F with the steroid receptors GR and androgen receptor (AR) in mammalian cells, we obtained results consistent with our data in yeast ( Figure 5F ). Y38F mutation minimally impacted hHsp90 interaction with either GR or AR ( Figure 5K, L) . Quantification of coimmunoprecipitated v-Src, ErbB2, GR, and AR with hHsp90-Y38F confirms the robustness of these observations ( Figure S5 ).
Taken together, these data show that not all aspects of Hsp90 function or Hsp90-client interactions are uniformly affected by Y24/Y38 phosphorylation. While this modification significantly affects the interaction/activity of several kinases and suppression of HSF activity, it seems to have minimal significance for steroid receptor interaction/activity, for Hsp90 ATP binding and ATPase activity, and for support of yeast viability.
Hsp90 Y24/Y38 mutation impacts Hsp90 association with a specific subset of co-chaperones
Like post-translational modifications, co-chaperones also play an important role in regulating Hsp90 activity. Therefore, we examined the impact of Y24/Y38 phosphorylation status on cochaperone interactions with Hsp90. Yeast cells expressing yHsp90His 6 in the presence or absence of Swe1 and yeast cells expressing yHsp90His 6 -Y24F were subjected to affinity pulldown with Ni-NTA agarose, and associating co-chaperones were examined by Western blot analysis. yHsp90 from swe1Δ cells and yHsp90-Y24F interacted equivalently with Sti1 Hop and Cdc37 p50 compared to wt yHsp90. In contrast, Aha1 association with yHsp90-Y24F and with yHsp90 expressed in swe1Δ cells was completely abrogated, while the association of Sba1 p23 was reduced compared to wt yHsp90 ( Figure 6A, B) . These results strongly suggest that Swe1-mediated phsophorylation of Y24 affects yHsp90 binding to a specific subset of co-chaperones, which may in turn affect the conformational dynamics of Hsp90.
Comparable results were observed when we examined the interaction of hHsp90α-Y38F with mammalian co-chaperones. COS7 cells were transiently transfected with FLAG-hHsp90α or its Y38F mutant. Wild type hHsp90α interacted with Aha1, p23, p60 Hop , and p50 cdc37 ( Figure  6C, D) . However, hHsp90α-Y38F did not interact at all with Aha1 and its association with p23 was reduced, while interaction with p50 cdc37 and p60 Hop was not affected by this mutation (Figure 6C, D) .
Pharmacologic inhibition/molecular knockdown of Wee1 sensitizes cancer cells to an Hsp90 inhibitor
Although the binding affinity of GA for purified wt and yHsp90-Y24F is comparable (Kd wt = 2.6 +/-0.27 μM, Kd Y24F = 3.6 +/-0.32 μM), we examined GA affinity bead binding to Hsp90 in lysates of yeast cells expressing yHsp90-Y24F, or in swe1Δ yeast lysates expressing wt yHsp90. To our surprise, when compared to wt yHsp90 in Swe1-expressing yeast cells, GAbead binding to both yHsp90 in swe1Δ cells and to yHsp90-Y24F in Swe1-expressing cells was reproducibly increased, suggesting a contribution of epigenetic factors to GA binding in vivo that are not present in vitro ( Figure 7A ). We also observed increased GA-bead binding to hHsp90α-Y38F, compared to wt hHsp90α, from COS7 cell lysates ( Figure 7B ). Hsp90 binding to GA-beads is specific, as pretreating the protein lysates with 10 μM soluble GA completely prevented Hsp90 binding to GA-beads ( Figure 7C ). In contrast to GA binding, ATP binding to yHsp90 from each lysate was identical ( Figure 7A ). The lack of impact of the Y24F mutation on ATP binding was consistent with our in vitro data obtained with purified yHsp90 and yHsp90-Y24F proteins ( Figure 4B ).
These observations suggested that inhibition/silencing of Wee1 might sensitize cancer cells to GA. To test this hypothesis, we first used a Wee1 inhibitor that is a potent competitor of ATP binding (Palmer et al., 2006) . Using the in vitro assay described earlier, we titrated this compound to obtain a concentration that inhibited both Wee1 autophosphorylation and Wee1-mediated phosphorylation of hHsp90 (occurring at a concentration ≥1 μM, Figure 7D ). Next, we treated two cancer cell lines, PC3 (prostate carcinoma) and HeLa (cervical carcinoma), with Wee1 inhibitor (2.5 μM for PC3 cells and 5 μM for HeLa cells) for 24 hrs, followed by 0 -80 nM 17-AAG (a clinically well-tolerated Hsp90 inhibitor derived from GA) for an additional 48 h (in the continued presence of Wee1 inhibitor). At the end of the incubation period we quantified the percentage of apoptotic cells by flow cytometry (by measuring the increase in amount of sub-G1 cellular DNA content, shaded bars, Figure 7E, F) . For comparison, cells were treated with 17-AAG alone (open bars, Figure 7E, F) . Compared to either Wee1 inhibitor alone or 17-AAG alone, combined administration of both drugs had a greater than additive impact on apoptosis that was dose-dependently related to the concentration of 17-AAG.
We confirmed this observation in PC3 cells by assessing the abundance of cleaved caspase-3 and cleaved PARP, two cellular markers of apoptosis. Treatment as above with the combination of Wee1 inhibitor (2.5 μM) and 17-AAG (40 & 60 nM) noticeably increased the level of both apoptotic markers, while similar incubation with the individual drugs was ineffective ( Figure  7G ).
Finally, we repeated this experiment using Wee1-specific siRNA to silence Wee1 expression. Forty-eight hours after siRNA transfection, Wee1 mRNA and protein were reduced by 80 % ( Figure 7H ). We added 17-AAG (50 nM) for an additional 48 hours and monitored the abundance of cleaved caspase-3 and cleaved PARP. When contrasted with either Wee1 silencing alone or 17-AAG alone, Wee1 silencing combined with 17-AAG led to a marked increase of both apoptotic indicators ( Figure 7I ).
Discussion
We show here that Swe1 Wee1 phosphorylates a conserved tyrosine residue in the N-domain of Hsp90 both in vivo and in vitro. This finding was unexpected as Swe1 is thought to singularly regulate Cdc28 Cdc2 . Our data suggest Swe1 phosphorylates yHsp90 in the nucleus, and that cytosolic relocation of phosphotyrosyl yHsp90 likely precedes its ubiquitination and degradation by the proteasome. We propose that proteasomal degradation of tyrosine phosphorylated Hsp90 is the "switching off" mechanism for this form of the chaperone, at least in yeast.
Our data identify Y24 as the target of Swe1 and the sole phosphotyrosine in yHsp90. This residue is conserved in higher eukaryotes and Swe1 is able to phosphorylate the equivalent tyrosine residue in human Hsp90α, Y38, when this protein is expressed in yeast. Further, purified Wee1 phosphorylated both yHsp90 and hHsp90α in vitro, but only on Y24/Y38. When expressed as the sole Hsp90 protein, yHsp90-Y24F supported yeast growth but caused Swe1 destabilization (data not shown, manuscript in preparation), with the cells behaving like swe1Δ mutants (e.g., having a short G2 and loss of DNA damage check point, unpublished data). This raises the possibility that Swe1 is among a subset of client proteins whose stability and function depend on association with tyrosine phosphorylatable Hsp90, even though this modification is dispensable for yeast viability. yHsp90-Y24F failed to productively chaperone two endogenous yeast protein kinases, Ste11 and Mpk1/Slt2, as well as exongenous v-Src expressed in yeast. Likewise, hHsp90-Y38F interacted poorly with v-Src, ErbB2, and Raf-1 kinases in mammalian cells, and similar results were obtained for wt hHsp90 following silencing of Wee1. Additionally, non-phosphorylatable Hsp90 demonstrated elevated basal and heat-induced HSF transcriptional activity. This phenotype was reproduced in yeast expressing wt Hsp90 but lacking Swe1 expression. In contrast, hHsp90α-Y38F interaction with the transcription factors GR and AR in mammalian cells was unaffected, and yHsp90-Y24F productively chaperoned GR in vivo. Again, swe1Δ yeast displayed an identical phenotype. Taken together, these findings underscore the differential impact of Y24/Y38 phosphorylation/mutation on Hsp90 function, and they identify a unique mechanism by which the intracellular environment might specifically modulate Hsp90 activity toward individual clients.
We also found the interaction of non-phosphorylatable Y24F yHsp90 or Y38F hHsp90α with Aha1 to be lost and interaction with Sba1 p23 to be significantly reduced both in yeast and in mammalian cells, suggesting that phosphorylation status of Y24/Y38 impacts the conformational dynamics of the Hsp90 chaperone cycle. This conclusion was strengthened by identical results obtained in swe1Δ yeast expressing wt yHsp90. As the in vitro binding constants of Aha1 to both wt and Y24F Hsp90 are similar (2.7 ± 0.34 vs 1.8 ± 0.33 μM, respectively), our data strongly suggest that Y24/Y38 phosphorylation status serves as a regulatable epigenetic modulator of Aha1 interaction with Hsp90.
Since yHsp90-Y24E and -Y24D mutants were not viable, we were not able to query the consequences of these phosphomimic mutations on Hsp90 function in vivo. While it is possible that tyrosine phosphorylation is restricted to a subpopulation of Hsp90 in vivo because this modification is incompatible with key aspects of chaperone function necessary for yeast viability, we cannot rule out the possibility that structural alterations accompanying these mutations are harmful for Hsp90 function. Y24 is among a group of residues that have been shown to form an interacting cluster in ATP-bound Hsp90 (Cunningham et al., 2008) . The hydrophobic interactions established by this cluster are essential for N-domain dimerization and are necessary for active site formation and for ATPase activity (Cunningham et al., 2008; Morra et al., 2009) . Indeed, while Swe1 is able to phosphorylate Hsp90-D79N, which exists in an open conformation at equilibrium (Y24 exposed to solvent), it is unable to phosphorylate Hsp90-E33A, which favors a closed (N-domain dimerized) conformation (Y24 buried in hydrophobic cluster, Figure S6 ). Thus, it is not surprising that yHsp90-Y24E protein has minimal ATPase activity and fails to undergo N-domain dimerization in the presence of AMPPNP, even though nucleotide binding to this mutant is comparable to that of wt yHsp90. In contrast, the ATPase activity of yHsp90-Y24F is unchanged from wt. These data emphasize the importance of the hydrophobic character of this residue, as a previous study found that the ATPase activity of yHsp90-Y24A was reduced nearly 5-fold compared to wt (Cunningham et al., 2008) .
While it remains to be determined whether Y24/Y38 phosphorylation has a similar impact on Hsp90 ATPase activity as does phosphomimic mutation, the sum of our data predict that the hydrophobic interactions in which Y24/Y38 participate, and which are necessary for ATPase activity, are likely to be disrupted by tyrosine phosphorylation. The necessity of Y24/Y38 phosphorylation for chaperoning certain kinases and suppressing HSF activity is difficult to explain, but it may reflect a need of some client proteins for prolonged association with a conformationally restricted, ATPase-incompetent form of Hsp90.
Finally, we explored the impact of Y24/Y38 phosphorylation on the ability of Hsp90 to interact with the prototypical ATP binding pocket inhibitor GA. We found that, in yeast lysates, yHsp90-Y24F and hHsp90-Y38F bound more efficiently to GA-beads compared to wt Hsp90, and we verified these results using swe1Δ cells expressing wt Hsp90. In agreement with these data, the Hsp90 bound to GA-beads is not tyrosine phosphorylated ( Figure S6 ). Neither Swe1 deletion nor Hsp90 mutation affected the binding of ATP. Next, we demonstrated that concomitant pharmacologic inhibition of Wee1 and Hsp90 induced significant apoptosis in two cancer cell lines, although neither drug alone was able to do so at the concentrations used. These results were confirmed by analysis of two apoptosis markers, cleaved caspase-3 and cleaved PARP. In each case, the drug combination was much more effective than either inhibitor alone. Silencing of Wee1, combined with Hsp90 inhibition, produced identical results. These data are consistent with the observation that both swe1Δ yeast and yeast expressing only yHsp90-Y24F are more sensitive to GA (data not shown), and they suggest that the inability of Hsp90 to chaperone specific clients, or to interact with specific co-chaperones, may enhance cellular sensitivity to Hsp90 inhibitors. Indeed, two previous studies have reported that knockdown of Aha1 and p23 enhance mammalian and yeast cell sensitivity, respectively, to Hsp90 inhibition (Forafonov et al., 2008; Holmes et al., 2008) . Our data provide a novel approach to exploit these observations in the clinic, while at the same time identifying a unique post-translational modification of Hsp90 that differentially regulates chaperoning of specific client proteins.
Experimental Procedures Yeast Strains and Growth Media
The yeast strains used in this study pp30-Swe1HA (SWE1HA6-HIS3MX6) and pp30-swe1Δ (SWE1HIS3MX6) were derived from pp30 (MAT a, 112, hsc82KANMX4, hsp82KANMX4) , (Panaretou et al., 1998) . Genetic manipulations and media conditions for both yeast and mammalian cells are detailed in Supplemental Data.
Protein Analysis and Immunoblotting
Total protein extracts were prepared and analyzed as previously described (Panaretou and Piper, 1996) . Detailed protein precipitations and detection by Western blotting for both yeast and mammalian cells are presented in Supplemental Data.
Yeast Nuclear Extract
Nuclear and cytoplasmic protein extracts were prepared from yeast cells using a modified method on Dr. Steven Hahn's laboratory website (http://labs.fhcrc.org/hahn/Methods/biochem_meth/polii_nuc_ext.html). Additional details are found in Supplemental Data.
In Vitro Kinase Assay
Yeast Hsp90 and the Y24F mutant, as well as human Hsp90α and the Y38F mutant, were Nterminally His6 tagged using pRSETA plasmid. They were expressed in bacteria, and 2mg of protein extracts were incubated with 50 μl of Ni-NTA agarose (Qiagen). 200 ng of baculovirus expressed and purified Wee1-GST (Invitrogen) were used in the kinase assay. Wee1 kinase reactions were as previously described (Lees-Miller and Anderson, 1989) Ste11ΔN, Mpk1/Slt2, v-Src, GR and HSE-LacZ Activation Assays Ste11ΔN induction and Mpk1/Slt2 activation were analyzed as previously described (Louvion et al., 1998; Millson et al., 2004) . Ste11ΔN plasmid is a gift of Jill Johnson. v-Src induction and activation were analyzed as previously described (Vaughan et al., 2008) . Expressed v-Src protein was detected with EC10 mouse antibody (Millipore), and v-Src activity with 4G10 mouse anti-phosphotyrosine antibody (Millipore). GR assay was performed as previously described (Garabedian and Yamamoto, 1992) , as was measurement of HSE-LacZ expression (Hjorth-Sorensen et al., 2001) . Additional details are found in Supplemental Data.
Hsp90 ATPase Activity and Cross-Linking Assays
ATPase activity and Hsp90 cross-linking were measured as previously described (Panaretou et al., 1998) . All activities are averages of three separate measurements.
Isothermal Titration Calorimetry (ITC) and K d Determinations
ITC and K d determinations were performed as previously described (Panaretou et al., 1998) . Additional information can be found in Supplemental Data
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Figure 1. Swe1 phosphorylates yHsp90
A) His6 tagged yHsp90 was precipitated from untreated or GA-treated (100 μM, 1 h) yeast cells and its tyrosine phosphorylation was detected with anti-phosphotyrosine antibody. B) Deletion of SWE1 abolishes tyrosine phosphorylation of yHsp90. C) Over-expression of GST tagged Swe1 in swe1Δ cells restores tyrosine phosphorylation of yHsp90. Swe1-GST was detected by anti-GST antibody. A) Yeast cells were arrested in G1 (with α-factor), in S-phase (with hydroxyurea, HU), and in M-phase (with nocodazole, NOC), and yHsp90 tyrosine phosphorylation was assessed. Cdc28 Tyr19 phosphorylation is shown as an indicator of Swe1 activity. Cdc28 interaction with yHsp90 was detected by α-PSTAIRE antibody. B) Treatment of yeast with 0.1 mM bpV(Phen) did not increase tyrosine phosphorylation of yHsp90. Increase phosphorylation of Cdc28-Tyr19 was used as an indicator of phosphatase inhibition. Cdc28 Cdc2 was detected by anti-PSTAIRE-antibody and Swe1-HA by anti-HA antibody. C) Wild type or swe1Δ yeast cells expressing His6 tagged yHsp90 were treated with the proteasome inhibitor MG132 (50 μM for 1 h), and yHsp90 tyrosine phosphorylation and 
A)
In vivo activity of phospho-and nonphosphomimic Hsp90 mutations. Phosphomimic mutants abolished viability, whereas the non-phosphorylatable mutants support yeast growth. B) ATPase activity of bacterially expressed and purified wt yHsp90, yHsp90-Y24F, and yHsp90-Y24E proteins was determined as described in Methods. Kd of each protein for AMPPNP is shown in inset. C) AMPPNP-dependent N-domain dimerization of wt yHsp90, yHsp90-Y24F, and yHsp90-Y24E proteins was determined as described in Methods. After crosslinking and polyacrylamide gel electrophoresis, N-domain dimerized Hsp90 runs with an apparent molecular weight of approximately 190 kD. D) Averaged densitometry scans of results shown in Figure 4B and two additional experiments. Gels were scanned and where necessary normalized against total intensity. The peak representing the slowest migrating band (identified by the black arrow) indicates the degree of N-terminally dimerized wt or mutant Hsp90 protein.
